Thomas J. Herzfeld Advisors, Inc. Morpho Sys Ag Transaction History

Thomas J. Herzfeld Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.81 - $30.33 $7,542 - $9,220	-304 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$24.08 - $33.35 $6,429 - $8,904	-267 Reduced 46.76%	304 $10,000
Q1 2020 May 13, 2020	SELL	$18.86 - $37.36 $5,016 - $9,937	-266 Reduced 31.78%	571 $14,000
Q3 2019 Nov 08, 2019	BUY	$24.18 - $31.58 $20,238 - $26,432	837 New	837 $23,000

1.8M

14.7K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.